AFT Pharmaceuticals Ltd banner
A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 4.37 NZD 1.16% Market Closed
Market Cap: NZ$458.3m

Wall St Price Targets

AFT Price Forecast
Based on 3 analysts

+9% Upside
from NZ$4.37 today

AFT Pharmaceuticals Ltd (AFT)’s 12-month stock price forecast through October 2027 has a consensus target of NZ$4.74, implying 9% upside. The forecast is based on price targets from 3 Wall Street analysts.

AFT Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for AFT yet.

AFT Pharmaceuticals Ltd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AFT's stock price target?
Price Target
4.74 NZD

According to Wall Street analysts, the average 1-year price target for AFT is 4.74 NZD with a low forecast of 4.29 NZD and a high forecast of 5.3 NZD.

What is the Revenue forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 4 years is 15%.

What is the Gross Profit forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next -1 years is 15%.

What is the Operating Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Operating Income has been 27%. The projected CAGR for the next 4 years is 20%.

What is the Pre-Tax Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 39%. The projected CAGR for the next 3 years is 26%.

What is the Net Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
23%

Over the last 13 years, the compound annual growth rate for Net Income has been 41%. The projected CAGR for the next 4 years is 23%.

Back to Top